{
  "id": 13073362,
  "title": "Retension Pharmaceuticals prices upsized IPO at $12 per share",
  "url": "https://urgent.news/2026/10/09/retension-pharmaceuticals-prices-upsized-ipo-at-12-per-share",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-09T08:43:07.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4651659-retension-pharmaceuticals-prices-upsized-ipo-at-12-per-share?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "TRexBio prices $117M IPO at $14 per share",
        "url": "https://urgent.news/2026/10/09/trexbio-prices-117m-ipo-at-14-per-share",
        "published": "2026-10-09T07:24:13.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}